Cargando…

Prevention of Type 2 Diabetes with the Chinese Herbal Medicine Tianqi Capsule: A Systematic Review and Meta-Analysis

INTRODUCTION: Prevention of the rapid growth in incidence of type 2 diabetes (T2DM) is a big challenge for clinicians. In China, many trials have indicated that Tianqi capsule, which contains several Chinese herbal medicines as part of a large healing system called traditional Chinese medicine, coul...

Descripción completa

Detalles Bibliográficos
Autores principales: Pang, Bing, Zhang, Ying, Liu, Jing, He, Li-sha, Zheng, Yu-jiao, Lian, Feng-mei, Tong, Xiao-lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688982/
https://www.ncbi.nlm.nih.gov/pubmed/29027648
http://dx.doi.org/10.1007/s13300-017-0316-x
_version_ 1783279289128452096
author Pang, Bing
Zhang, Ying
Liu, Jing
He, Li-sha
Zheng, Yu-jiao
Lian, Feng-mei
Tong, Xiao-lin
author_facet Pang, Bing
Zhang, Ying
Liu, Jing
He, Li-sha
Zheng, Yu-jiao
Lian, Feng-mei
Tong, Xiao-lin
author_sort Pang, Bing
collection PubMed
description INTRODUCTION: Prevention of the rapid growth in incidence of type 2 diabetes (T2DM) is a big challenge for clinicians. In China, many trials have indicated that Tianqi capsule, which contains several Chinese herbal medicines as part of a large healing system called traditional Chinese medicine, could decrease the incidence of T2DM. The review assessed the effectiveness of Tianqi capsule in prevention of T2DM. METHODS: Seven electronic databases were searched to identify eligible trials published from the inception of the databases up until May 1, 2017. Randomized controlled trials (RCTs) of Tianqi capsule for impaired glucose tolerance (IGT) were included. Data extraction and quality assessment were performed according to the Cochrane review standards. A random or a fixed effect model was used to analyze outcomes which were expressed as risk ratios (RRs) or mean differences (MD), and I (2) statistics were used to assess heterogeneity. RESULTS: Six trials were identified that included 1027 subjects. Meta-analysis showed that subjects who received Tianqi capsule plus lifestyle modification (LM) were less likely to progress to T2DM compared to controls (RR 0.55, 95% CI 0.44–0.68). Subjects who received Tianqi capsule plus LM were more likely to have glucose return to normal compared to controls (RR 0.69; 95% CI 0.62–0.78); and they had reduced fasting plasma glucose (FBG) (MD − 0.35; 95% CI − 0.55 to − 0.16) and 2-h plasma glucose (2 h PG) (MD − 1.04; 95% CI − 1.75 to − 0.32). There was no statistical difference between the two groups for IGT stabilized incidence (RR 0.89; 95% CI 0.71–1.12). No obvious adverse events occurred. CONCLUSION: In patients with IGT, Tianqi capsule reduced the risk of progression to T2DM and increased the possibility of regression toward normoglycemia. As a result of the limited number of RCTs and the methodological drawbacks of the included studies, the results should be interpreted with caution.
format Online
Article
Text
id pubmed-5688982
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-56889822017-11-29 Prevention of Type 2 Diabetes with the Chinese Herbal Medicine Tianqi Capsule: A Systematic Review and Meta-Analysis Pang, Bing Zhang, Ying Liu, Jing He, Li-sha Zheng, Yu-jiao Lian, Feng-mei Tong, Xiao-lin Diabetes Ther Review INTRODUCTION: Prevention of the rapid growth in incidence of type 2 diabetes (T2DM) is a big challenge for clinicians. In China, many trials have indicated that Tianqi capsule, which contains several Chinese herbal medicines as part of a large healing system called traditional Chinese medicine, could decrease the incidence of T2DM. The review assessed the effectiveness of Tianqi capsule in prevention of T2DM. METHODS: Seven electronic databases were searched to identify eligible trials published from the inception of the databases up until May 1, 2017. Randomized controlled trials (RCTs) of Tianqi capsule for impaired glucose tolerance (IGT) were included. Data extraction and quality assessment were performed according to the Cochrane review standards. A random or a fixed effect model was used to analyze outcomes which were expressed as risk ratios (RRs) or mean differences (MD), and I (2) statistics were used to assess heterogeneity. RESULTS: Six trials were identified that included 1027 subjects. Meta-analysis showed that subjects who received Tianqi capsule plus lifestyle modification (LM) were less likely to progress to T2DM compared to controls (RR 0.55, 95% CI 0.44–0.68). Subjects who received Tianqi capsule plus LM were more likely to have glucose return to normal compared to controls (RR 0.69; 95% CI 0.62–0.78); and they had reduced fasting plasma glucose (FBG) (MD − 0.35; 95% CI − 0.55 to − 0.16) and 2-h plasma glucose (2 h PG) (MD − 1.04; 95% CI − 1.75 to − 0.32). There was no statistical difference between the two groups for IGT stabilized incidence (RR 0.89; 95% CI 0.71–1.12). No obvious adverse events occurred. CONCLUSION: In patients with IGT, Tianqi capsule reduced the risk of progression to T2DM and increased the possibility of regression toward normoglycemia. As a result of the limited number of RCTs and the methodological drawbacks of the included studies, the results should be interpreted with caution. Springer Healthcare 2017-10-13 2017-12 /pmc/articles/PMC5688982/ /pubmed/29027648 http://dx.doi.org/10.1007/s13300-017-0316-x Text en © The Author(s) 2017 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Review
Pang, Bing
Zhang, Ying
Liu, Jing
He, Li-sha
Zheng, Yu-jiao
Lian, Feng-mei
Tong, Xiao-lin
Prevention of Type 2 Diabetes with the Chinese Herbal Medicine Tianqi Capsule: A Systematic Review and Meta-Analysis
title Prevention of Type 2 Diabetes with the Chinese Herbal Medicine Tianqi Capsule: A Systematic Review and Meta-Analysis
title_full Prevention of Type 2 Diabetes with the Chinese Herbal Medicine Tianqi Capsule: A Systematic Review and Meta-Analysis
title_fullStr Prevention of Type 2 Diabetes with the Chinese Herbal Medicine Tianqi Capsule: A Systematic Review and Meta-Analysis
title_full_unstemmed Prevention of Type 2 Diabetes with the Chinese Herbal Medicine Tianqi Capsule: A Systematic Review and Meta-Analysis
title_short Prevention of Type 2 Diabetes with the Chinese Herbal Medicine Tianqi Capsule: A Systematic Review and Meta-Analysis
title_sort prevention of type 2 diabetes with the chinese herbal medicine tianqi capsule: a systematic review and meta-analysis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688982/
https://www.ncbi.nlm.nih.gov/pubmed/29027648
http://dx.doi.org/10.1007/s13300-017-0316-x
work_keys_str_mv AT pangbing preventionoftype2diabeteswiththechineseherbalmedicinetianqicapsuleasystematicreviewandmetaanalysis
AT zhangying preventionoftype2diabeteswiththechineseherbalmedicinetianqicapsuleasystematicreviewandmetaanalysis
AT liujing preventionoftype2diabeteswiththechineseherbalmedicinetianqicapsuleasystematicreviewandmetaanalysis
AT helisha preventionoftype2diabeteswiththechineseherbalmedicinetianqicapsuleasystematicreviewandmetaanalysis
AT zhengyujiao preventionoftype2diabeteswiththechineseherbalmedicinetianqicapsuleasystematicreviewandmetaanalysis
AT lianfengmei preventionoftype2diabeteswiththechineseherbalmedicinetianqicapsuleasystematicreviewandmetaanalysis
AT tongxiaolin preventionoftype2diabeteswiththechineseherbalmedicinetianqicapsuleasystematicreviewandmetaanalysis